Systemic metabolic alterations associated with increased consumption of saturated fat and obesity are linked with increased risk of prostate cancer progression and mortality, but the molecular underpinnings of this association are poorly understood. Here, we demonstrate in a murine prostate cancer model, that high-fat diet (HFD) enhances the MYC transcriptional program through metabolic alterations that favour histone H4K20 hypomethylation at the promoter regions of MYC regulated genes, leading to increased cellular proliferation and tumour burden. Saturated fat intake (SFI) is also associated with an enhanced MYC transcriptional signature in prostate cancer patients. The SFI-induced MYC signature independently predicts prostate cancer prog...
The global epidemic of obesity is closely linked to the development of serious co-morbidities, inclu...
Our fat produces hormones that provide our bodies feedback about energy stores. This feedback can tr...
Prostate cancer is the second-leading cause of cancer death in Australian men. Current therapies for...
Systemic metabolic alterations associated with increased consumption of saturated fat and obesity ar...
Systemic metabolic alterations associated with increased consumption of saturated fat and obesity ar...
Although recent evidence has suggested that a high-fat diet (HFD) plays an important role in prostat...
Cancer cells may overcome growth factor dependence by deregulating oncogenic and/or tumor-suppressor...
Prostate cancer is the second most common cancer diagnosed world-wide; however, patients demonstrate...
INTRODUCTION: An altered metabolic regulation is involved in the development and progression of diff...
Per- and polyfluoroalkyl substances (PFAS) are synthetic chemicals utilized in various industrial se...
Increased fat intake is known to be a major cause of prostate cancer. In this study, we investigated...
Cancer is increasingly recognized as an extraordinarily heterogeneous disease featuring an intricate...
Although there is an increase in the diagnosis of prostate cancer, most tumours remain organ-confine...
Advanced prostate cancer (PCa) represents the fifth cause of cancer death worldwide. Although surviv...
Prostate cancer (PCa) is the most commonly diagnosed malignant neoplasm in men in the Western world....
The global epidemic of obesity is closely linked to the development of serious co-morbidities, inclu...
Our fat produces hormones that provide our bodies feedback about energy stores. This feedback can tr...
Prostate cancer is the second-leading cause of cancer death in Australian men. Current therapies for...
Systemic metabolic alterations associated with increased consumption of saturated fat and obesity ar...
Systemic metabolic alterations associated with increased consumption of saturated fat and obesity ar...
Although recent evidence has suggested that a high-fat diet (HFD) plays an important role in prostat...
Cancer cells may overcome growth factor dependence by deregulating oncogenic and/or tumor-suppressor...
Prostate cancer is the second most common cancer diagnosed world-wide; however, patients demonstrate...
INTRODUCTION: An altered metabolic regulation is involved in the development and progression of diff...
Per- and polyfluoroalkyl substances (PFAS) are synthetic chemicals utilized in various industrial se...
Increased fat intake is known to be a major cause of prostate cancer. In this study, we investigated...
Cancer is increasingly recognized as an extraordinarily heterogeneous disease featuring an intricate...
Although there is an increase in the diagnosis of prostate cancer, most tumours remain organ-confine...
Advanced prostate cancer (PCa) represents the fifth cause of cancer death worldwide. Although surviv...
Prostate cancer (PCa) is the most commonly diagnosed malignant neoplasm in men in the Western world....
The global epidemic of obesity is closely linked to the development of serious co-morbidities, inclu...
Our fat produces hormones that provide our bodies feedback about energy stores. This feedback can tr...
Prostate cancer is the second-leading cause of cancer death in Australian men. Current therapies for...